ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 168 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $230,902 | -92.2% | 11,269 | -93.9% | 0.00% | -93.8% |
| Q3 2022 | $2,944,000 | -9.5% | 184,455 | -22.0% | 0.02% | -5.9% |
| Q2 2022 | $3,254,000 | -5.9% | 236,467 | +8.4% | 0.02% | -15.0% |
| Q1 2022 | $3,459,000 | +191.4% | 218,107 | +301.1% | 0.02% | +233.3% |
| Q4 2021 | $1,187,000 | -52.4% | 54,371 | +19.6% | 0.01% | -71.4% |
| Q4 2020 | $2,492,000 | +1191.2% | 45,448 | +229.1% | 0.02% | +250.0% |
| Q1 2020 | $193,000 | – | 13,811 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 715,880 | $9,851,000 | 11.04% |
| RTW INVESTMENTS, LP | 15,802,802 | $217,447,000 | 5.62% |
| Amitell Capital Pte Ltd | 97,331 | $1,339,000 | 3.05% |
| Prosight Management, LP | 276,802 | $3,809,000 | 3.00% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $17,419,000 | 2.64% |
| Affinity Asset Advisors, LLC | 250,466 | $3,446,000 | 1.45% |
| COWEN AND COMPANY, LLC | 1,000,000 | $13,760,000 | 1.33% |
| Boxer Capital, LLC | 1,466,051 | $20,173,000 | 1.28% |
| Cormorant Asset Management, LP | 868,550 | $11,951,000 | 0.90% |
| MAVERICK CAPITAL LTD | 2,532,366 | $34,845,000 | 0.86% |